Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,947 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: fukuda t. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis.
Shimomura Y, Komukai S, Kitamura T, Sobue T, Kurosawa S, Doki N, Katayama Y, Ozawa Y, Matsuoka KI, Tanaka T, Kako S, Sawa M, Kanda Y, Nakamae H, Nakazawa H, Ueda Y, Kanda J, Fukuda T, Atsuta Y, Ishiyama K. Shimomura Y, et al. Among authors: fukuda t. Bone Marrow Transplant. 2023 Feb;58(2):186-194. doi: 10.1038/s41409-022-01871-8. Epub 2022 Nov 14. Bone Marrow Transplant. 2023. PMID: 36376472
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
Yanagisawa R, Tamaki M, Tanoshima R, Misaki Y, Uchida N, Koi S, Tanaka T, Ozawa Y, Matsuo Y, Tanaka M, Ikegame K, Katayama Y, Matsuoka KI, Ara T, Kanda Y, Matsumoto K, Fukuda T, Atsuta Y, Kato M, Nakasone H. Yanagisawa R, et al. Among authors: fukuda t. Hematol Oncol. 2023 Aug;41(3):535-545. doi: 10.1002/hon.3101. Epub 2022 Nov 25. Hematol Oncol. 2023. PMID: 36385399
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N. Yanagisawa R, et al. Among authors: fukuda t. Int J Hematol. 2023 Mar;117(3):421-427. doi: 10.1007/s12185-022-03489-4. Epub 2022 Nov 20. Int J Hematol. 2023. PMID: 36403180
Novel risk assessment for the intensity of conditioning regimen in older patients.
Akahoshi Y, Tada Y, Sakaida E, Kusuda M, Doki N, Uchida N, Fukuda T, Tanaka M, Sawa M, Katayama Y, Matsuoka KI, Ozawa Y, Onizuka M, Kanda J, Kanda Y, Atsuta Y, Nakasone H. Akahoshi Y, et al. Among authors: fukuda t. Blood Adv. 2023 Sep 12;7(17):4738-4747. doi: 10.1182/bloodadvances.2022008706. Blood Adv. 2023. PMID: 36508283 Free PMC article.
Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real-world registry study in Japan.
Konuma T, Itonaga H, Ishiyama K, Hamamura A, Uchida N, Ozawa Y, Katayama Y, Sakurai M, Ueda Y, Matsuoka KI, Kawakita T, Eto T, Ara T, Kanda J, Onizuka M, Fukuda T, Atsuta Y. Konuma T, et al. Among authors: fukuda t. Am J Hematol. 2023 Apr;98(4):E68-E71. doi: 10.1002/ajh.26839. Epub 2023 Jan 24. Am J Hematol. 2023. PMID: 36633538 Free article. No abstract available.
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Kaida K, Ikegame K, Inoue T, Maruyama S, Ishii S, Uchida N, Doki N, Eto T, Fukuda T, Katayama Y, Takada S, Kawakita T, Ichinohe T, Atsuta Y, Daimon T, Ogawa H. Kaida K, et al. Among authors: fukuda t. Transplant Cell Ther. 2023 Apr;29(4):273.e1-273.e9. doi: 10.1016/j.jtct.2023.01.005. Epub 2023 Jan 12. Transplant Cell Ther. 2023. PMID: 36641032 Free article.
Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study.
Tokunaga M, Nakano N, Fuji S, Wake A, Utsunomiya A, Ito A, Eto T, Kawakita T, Mori Y, Moriuchi Y, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Ishitsuka K, Kanda J, Kimura T, Ichinohe T, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K. Tokunaga M, et al. Among authors: fukuda t. Bone Marrow Transplant. 2023 Apr;58(4):462-464. doi: 10.1038/s41409-023-01919-3. Epub 2023 Jan 21. Bone Marrow Transplant. 2023. PMID: 36681773 No abstract available.
Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.
Kimura SI, Akahoshi Y, Shiratori S, Okinaka K, Harada K, Uchida N, Doki N, Ikegame K, Nakamae H, Tanaka M, Takada S, Kawakita T, Matsuoka KI, Ara T, Ota S, Sawa M, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Nakasone H. Kimura SI, et al. Among authors: fukuda t. Open Forum Infect Dis. 2023 Mar 27;10(4):ofad163. doi: 10.1093/ofid/ofad163. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37089776 Free PMC article.
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.
Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, Sawa M, Maruyama Y, Ueda Y, Miyakoshi S, Katayama Y, Kawakita T, Kimura T, Onizuka M, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Kanda J, Nakasone H. Tamaki M, et al. Among authors: fukuda t. Cytotherapy. 2023 Nov;25(11):1220-1228. doi: 10.1016/j.jcyt.2023.06.002. Epub 2023 Jun 20. Cytotherapy. 2023. PMID: 37341665
4,947 results